Stay updated on ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial

Sign up to get notified when there's something new on the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.6.5' was added to the record history, and the previous 'Revision: v3.6.4' entry was removed. This update reflects the page's revision tracking activity rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-08-08T22:51:07.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.3 to v3.6.4, signaling a backend/UI update to the page. This change does not alter study data or content.
    Difference
    0.1%
    Check dated 2026-07-25T12:49:47.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    A new Study Status entry was added to the record history, reflecting an update to the trial's status. An older 2026-06-11 history item was removed.
    Difference
    0.3%
    Check dated 2026-07-18T08:46:29.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The Record History gains a new entry for Revision: v3.6.3. This signals a subsequent update to the study record's metadata on ClinicalTrials.gov.
    Difference
    0.1%
    Check dated 2026-07-03T23:16:48.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The record history adds a new revision entry for Revision: v3.6.2, indicating the page was updated from v3.6.0 to v3.6.2.
    Difference
    0.1%
    Check dated 2026-06-26T23:30:06.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The record history page now includes new quick-links (Check who can join, Find Contact Information) and displays an updated Study Status entry in the version list, reflecting interface enhancements to access study details.
    Difference
    1%
    Check dated 2026-06-12T23:35:50.000Z thumbnail image

Stay in the know with updates to ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page.